Abstract | BACKGROUND: 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors ( statins), which are widely used to lower plasma cholesterol levels, have been reported to have various pleiotropic effects such as protective effect of endothelial cells, angiogenic effect, antioxidant effect and anti-inflammatory effect. It is unclear, however, whether statins have any effects on the progression from left ventricular (LV) hypertrophy to heart failure in the established hypertrophied heart. METHODS AND RESULTS: C57BL/6 mice were treated with pitavastatin (pitava) or vehicle (control) from 2 weeks (established hypertrophy stage) after transverse aortic constriction (TAC) and the treatment was continued for 4 weeks. Pitavastatin significantly inhibited the progression from LV hypertrophy to heart failure as assessed on echocardiography. The cardiomyocyte cross-sectional area was significantly increased in the control group compared to the sham-operated mice ( sham group), but it was not significantly different between the control group and the pitava group at 6 weeks after TAC. Moreover, pitavastatin induced myocardial angiogenesis (ratio of number of endothelial cells to cardiomyocytes) and decreased the myocardial fibrosis and oxidative stress. The expression of angiopoietin-1 in the heart was significantly increased by pitavastatin at 6 weeks after TAC. CONCLUSIONS:
|
Authors | Yoshihito Kameda, Hiroshi Hasegawa, Akihiko Kubota, Hiroyuki Tadokoro, Yoshio Kobayashi, Issei Komuro, Hiroyuki Takano |
Journal | Circulation journal : official journal of the Japanese Circulation Society
(Circ J)
Vol. 76
Issue 5
Pg. 1159-68
( 2012)
ISSN: 1347-4820 [Electronic] Japan |
PMID | 22361916
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Angiopoietin-1
- Angpt1 protein, mouse
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Quinolines
- pitavastatin
|
Topics |
- Angiopoietin-1
(biosynthesis)
- Animals
- Blood Pressure
- Fibrosis
(etiology, metabolism, pathology, prevention & control)
- Gene Expression Regulation
(drug effects)
- Heart Failure
(etiology, metabolism, pathology, prevention & control)
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
(pharmacology)
- Hypertrophy, Left Ventricular
(complications, metabolism, pathology)
- Mice
- Myocardium
(metabolism, pathology)
- Neovascularization, Pathologic
(metabolism, pathology, prevention & control)
- Oxidative Stress
(drug effects)
- Quinolines
(pharmacokinetics)
- Time Factors
|